[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2636 followers Created: 2025-07-23 13:02:26 UTC Windward Bio begins global Phase X asthma trial for WIN378, an anti-TSLP monoclonal antibody with potential as long-acting and best-in-disease treatment. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [Post Link](https://x.com/OzmosiHealth/status/1948005787365986705)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2636 followers
Created: 2025-07-23 13:02:26 UTC
Windward Bio begins global Phase X asthma trial for WIN378, an anti-TSLP monoclonal antibody with potential as long-acting and best-in-disease treatment.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
/post/tweet::1948005787365986705